Alto Neuroscience (ANRO) Institutional Ownership → What’s Really Next for America… (From Porter & Company) (Ad) Free ANRO Stock Alerts $12.82 -1.02 (-7.37%) (As of 05/16/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial Media Institutional Ownership Changes (13F Filings) for Alto Neuroscience (NYSE:ANRO)Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$29.99MNumber ofInstitutional Sellers(last 12 months)0 Get ANRO Insider Trade Alerts Want to know when executives and insiders are buying or selling Alto Neuroscience stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ANRO Institutional Buying and Selling by Quarter Ad Crypto 101 MediaThe Overlooked Retirement Asset You Probably Don’t Own4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.Click here to access the Crypto Retirement Blueprint now. Alto Neuroscience Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2024AWM Investment Company Inc.299,147$4.59M0.6%N/A1.113% 5/15/2024 Price T Rowe Associates Inc. MD637,604$9.79M0.0%N/A2.372% 5/10/2024 Vanguard Group Inc.536,332$8.23M0.0%N/A1.995% 5/2/2024 Jennison Associates LLC458,599$7.04M0.0%N/A1.706% 4/30/2024 University of Texas Texas AM Investment Managment Co.22,175$340K0.1%N/A0.082% (Data available from 1/1/2016 forward) ANRO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ANRO shares? During the previous two years, the following institutional investors and hedge funds held shares of Alto Neuroscience shares: Price T Rowe Associates Inc. MD ($9.79M), Vanguard Group Inc. ($8.23M), Jennison Associates LLC ($7.04M), and AWM Investment Company Inc. ($4.59M), University of Texas Texas AM Investment Managment Co. ($340K).Learn more on ANRO's institutional investors. Which institutional investors have been buying Alto Neuroscience stock? The following institutional investors have purchased Alto Neuroscience stock in the last 24 months: Price T Rowe Associates Inc. MD ($637.60K), Vanguard Group Inc. ($536.33K), Jennison Associates LLC ($458.60K), AWM Investment Company Inc. ($299.15K), and University of Texas Texas AM Investment Managment Co. ($22.18K). How much institutional buying is happening at Alto Neuroscience? Institutional investors have bought a total of 1,953,857 shares in the last 24 months. This purchase volume represents approximately $29.99M in transactions. Related Companies: Erasca Institutional Ownership Mereo BioPharma Group Institutional Ownership Rani Therapeutics Institutional Ownership Terns Pharmaceuticals Institutional Ownership Harrow Institutional Ownership ADC Therapeutics Institutional Ownership Esperion Therapeutics Institutional Ownership Amarin Institutional Ownership Corbus Pharmaceuticals Institutional Ownership Nature's Sunshine Products Institutional Ownership This page (NYSE:ANRO) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersInvest in the "Trojan Horse" of Alzheimer's TreatmentBehind the MarketsGold Set to EXPLODE!Gold Safe ExchangeThe 1,000X Crypto PlaybookTrue Market InsidersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaCharles Payne Demystifies OptionsUnstoppable ProsperityThe #1 Crypto for AIWeiss RatingsWhy Is Gold On a MASSIVE rally? Huge AlertsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alto Neuroscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
